• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » risk_management

Items Tagged with 'risk_management'

ARTICLES

Responding to Sexual Activity on the Inpatient Psychiatric Unit

March 23, 2022
Husna Najand, MD.
From The Carlat Hospital Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Husna Najand, MD. Olive View—UCLA Psychiatry Residency Program. Dr. Najand has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
The unit staff inform you that two patients on the unit are engaging in sexual activity. What do you do next? Dr Najand reviews guidelines for managing sexual incidents, both consensual and nonconsensual.
Read More

The “Z-Drugs”: Safety Issues and Misuse Potential

June 10, 2020
Rehan Aziz, MD.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Once heralded for their relative safety compared to benzodiazepines, the “Z-drugs” are now known to be one of the most common causes of adverse drug events. Here we review the risks of Z-drugs and highlight updated dosing recommendations for zolpidem.
Read More

Muscle Relaxants: Sedatives Often Under the Radar

June 10, 2020
Michael Weaver, MD, FASAM.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Michael Weaver, MD, FASAM. Professor and medical director at the Center for Neurobehavioral Research on Addictions at the University of Texas Medical School. Author of Addiction Treatment (Carlat Publishing, 2017). Dr. Weaver has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Muscle relaxants encompass medications with different mechanisms of action—many of which have been used for decades. Yet most are sedating, can have significant side effects, and can interact with opioids and other substances to worsen CNS and respiratory depression.
Read More

Electronic Communication with Patients: Advantages and Risks

January 1, 2015
Julianna Troy, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Julianna Troy, MD Staff Psychiatrist, Counseling and Psychological Services, Purdue University, Lafayette, IN Dr. Troy has disclosed that she has no relevant relationships or commercial interests in any companies related to this educational activity.
Do you use email to communicate with your patients? Chances are good that you don’t.
Read More

Assessing Suicide Risk and Documenting Your Care

January 1, 2015
William H. Reid, MD, MPH
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
William H. Reid, MD, MPH Psychiatrist in Private Practice, Horseshoe Bay, TX, Past-President, American Academy of Psychiatry and the Law, Clinical Professor of Psychiatry, Texas Tech University Health Sciences Center Dr. Reid has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity. He also notes that he is not a lawyer, and nothing in his words should be construed as legal advice.
Get some practical advice on how to assess a patient’s suicide risk and document your care to help protect against a malpractice lawsuit, in an interview with William H. Reid, MD, MPH, a clinical professor of psychiatry at Texas Tech University Health Sciences Center.
Read More

Botox Injections Work as Antidepressant

January 1, 2015
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Botulinum toxin A, commonly known as Botox, may be more than an anti-aging treatment. A new study has found that when Botox is injected between the eyebrows, it not only has a cosmetic effect—it also yields a long-lasting antidepressant effect.
Read More

Debate Rages On Over ‘Black Box’ Warning on Antidepressants

November 1, 2014
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
The psychiatric community continues to debate the value of the US Food and Drug Administration's (FDA) so-called ‘black box’ warning on certain antidepressants, and a pair of opposing viewpoints was recently featured in the New England Journal of Medicine.
Read More

Family-School Intervention Can Reduce Adolescent Alcohol Use

December 1, 2013
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Australian researchers recently reported data on the impact of a program called Resilient Families—an intervention aimed at preventing early use of alcohol, as well as frequent and heavy alcohol use, among adolescents in secondary schools in Melbourne.
Read More
Introducing Carlat Total Access Subscriptions

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • CMFB2e_Cover.png

    (PRE-ORDER) Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

    All the important facts covering child and adolescent psychopharmacology.
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto11543850.jpg
    General Psychiatry

    Elvis, Adderall, and a Broken Heart - Part 1

    A new medical investigation changes our understanding of Elvis Presley’s untimely death and offer some pearls for modern psychiatric practice.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.